ArticleJournal of physiology and biochemistry2018

7,8-Dihydroxycoumarin exerts antitumor potential on DMBA-induced mammary carcinogenesis by inhibiting ERα, PR, EGFR, and IGF1R: involvement of MAPK1/2-JNK1/2-Akt pathway.

Abhishek Kumar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.